GE HealthCare Technologies Inc.
General ticker "GEHC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $33.6B (TTM average)
GE HealthCare Technologies Inc. does not follow the US Stock Market performance with the rate: -13.1%.
Estimated limits based on current volatility of 1.6%: low 63.32$, high 65.32$
Factors to consider:
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Company pays dividends (irregularly): last record date 2026-07-24, amount 0.04$ (Y0.06%)
- Total employees count: 54000 (+1.9%) as of 2025
- China accounted for 10.9% of revenue in the fiscal year ended 2024-12-31
- US accounted for 43.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Geopolitical risks, Healthcare cost pressures, Strategic risks and growth management, R&D investment risks
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [70.29$, 99.38$]
- 2026-12-31 to 2027-12-31 estimated range: [73.99$, 104.67$]
Financial Metrics affecting the GEHC estimates:
- Positive: with PPE of 18.2 at the end of fiscal year the price was neutral
- Positive: 11.29 < Operating profit margin, % of 13.40
- Positive: 4.90 < Operating cash flow per share per price, % of 5.23
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Positive: Interest expense per share per price, % of 1.16 <= 1.42
- Negative: negative Industry operating cash flow (median)
Short-term GEHC quotes
Long-term GEHC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $19,552.00MM | $19,672.00MM | $20,625.00MM |
| Operating Expenses | $17,117.00MM | $17,047.00MM | $17,862.00MM |
| Operating Income | $2,435.00MM | $2,625.00MM | $2,763.00MM |
| Non-Operating Income | $-74.00MM | $-44.00MM | $5.00MM |
| Interest Expense | $542.00MM | $504.00MM | $440.00MM |
| R&D Expense | $1,205.00MM | $1,311.00MM | $1,260.00MM |
| Income(Loss) | $2,361.00MM | $2,581.00MM | $2,768.00MM |
| Taxes | $743.00MM | $531.00MM | $614.00MM |
| Other Income(Loss) | $-4.00MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $1,568.00MM | $1,993.00MM | $2,084.00MM |
| Stockholders Equity | $7,133.00MM | $8,446.00MM | $10,379.00MM |
| Inventory | $1,960.00MM | $1,939.00MM | $2,234.00MM |
| Assets | $32,454.00MM | $33,089.00MM | $36,906.00MM |
| Operating Cash Flow | $2,101.00MM | $1,951.00MM | $1,987.00MM |
| Capital expenditure | $387.00MM | $401.00MM | $482.00MM |
| Investing Cash Flow | $-558.00MM | $-914.00MM | $-1,047.00MM |
| Financing Cash Flow | $-478.00MM | $-573.00MM | $617.00MM |
| Earnings Per Share** | $3.45 | $4.37 | $4.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.